SCHEMBL7714917

SCHEMBL7714917

COc1cc(N)c(Cl)cc1CC(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.54
NPC1 O15118 1/20 0.53
HSD17B10 Q99714 1/20 0.51
HTR4 Q13639 5/20 0.45
CYP3A4 P08684 3/20 0.45
HTR3A P46098 3/20 0.45
CYP1A2 P05177 2/20 0.45
CYP2D6 P10635 2/20 0.45
CYP2C9 P11712 1/20 0.45
TSHR P16473 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HTR3E A5X5Y0 2/20 0.44
HTR3B O95264 2/20 0.44
HTR3D Q70Z44 2/20 0.44
HTR3C Q8WXA8 2/20 0.44
SLC22A1 O15245 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
MPO P05164 1/20 0.44
ADRA2A P08913 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3326963 0.85 HSD17B10 (0.56) GAAHSD17B10CYP3A4TSHRALDH1A1
SCHEMBL21198296 0.81 HSD17B10 (0.51) GAAHSD17B10CYP3A4TSHRALDH1A1
SCHEMBL21197947 0.81 HSD17B10 (0.51) GAAHSD17B10CYP3A4TSHRALDH1A1
SCHEMBL4549702 0.81 GAA (0.53) GAANPC1HSD17B10CYP3A4CYP1A2
SCHEMBL10287456 0.81 HSD17B10 (0.51) GAAHSD17B10HTR4CYP3A4TSHR
SCHEMBL31306573 0.81 HSD17B10 (0.51) GAAHSD17B10CYP3A4TSHRALDH1A1
SCHEMBL11420544 0.80 HSD17B10 (0.67) GAAHSD17B10CYP3A4TSHRSMN1; SMN2
SCHEMBL8970902 0.80 GAA (0.47) GAANPC1HTR4CYP3A4HTR3A
SCHEMBL98752 0.80 NPC1 (0.60) GAANPC1HTR4CYP3A4HTR3A
SCHEMBL17622509 0.79 GAA (0.42) GAACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0865421-B1 ARYLETHANOLAMINE DERIVATIVES AND THEIR USE AS AGONISTS OF ATYPICAL BETA-ADRENOCEPTORS GLAXO GROUP LTD (GB) 2002-03-27 EP disclosed
US-6048872-A DIETETICS; ANTIDIABETIC AGENTS; CARDIOVASCULAR DISORDERS; GASTROINTESTINAL DISORDERS GLAXO WELLCOME INC. (US) 2000-04-11 US disclosed
EP-0865421-A1 ARYLETHANOLAMINE DERIVATIVES AND THEIR USE AS AGONISTS OF ATYPICAL BETA-ADRENOCEPTORS GLAXO GROUP LIMITED (GB) 1998-09-23 EP disclosed
WO-1997021665-A1 ARYLETHANOLAMINE DERIVATIVES AND THEIR USE AS AGONISTS OF ATYPICAL BETA-ADRENOCEPTORS GLAXO GROUP LIMITED (GB) 1997-06-19 WO disclosed